41m
Stockhead on MSNHealth Check: Opthea’s solvency in question after monumental phase III eye disease trial failureOne of two of Opthea's phase III trials for a common eye disease has failed to meet its primary endpoints, ... Read More The ...
27m
Stockhead on MSNAstral Resources’ gold hits point to Kamperman as Mandilla satellite depositAstral Resources is increasingly confident the Kamperman deposit will boost economics of its Mandilla gold project after ...
A rare Bible that was donated to a charity shop in the UK has sold for a staggering £56,000 ($115,000) at auction. The book, ...
Oil prices held steady on Monday as investors assessed the outlook for ceasefire talks aimed at ending the Russia-Ukraine war ...
This nation triumphed with a score of 58.4 out of 100 based on 24 key criteria, including economic strength, living costs and ...
This growth stock has major plans. The post I'd buy this exciting ASX small-cap stock which plans to double in size by 2030 ...
A high street bakery chain with more than 100 stores and which rivals Greggs in some parts of Britain is at risk of going ...
A leading expert recommends buying the dip on Pro Medicus shares. The post Up 129% in a year, here are 3 reasons to buy Pro ...
While he’s known for giving participants some hard truths on Married At First Sight, not every one of John Aiken’s fiery ...
Tiger Woods has sparked a social media meltdown after confirming he's dating Vanessa Trump - the former daughter-in-law of ...
Campaigners have urged the Government to crack down on the Motability scheme to end spiralling costs, as concerns grow that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results